CONMED CORPORATION Legal Fees
CONMED CORPORATION (CNMD) reported Legal Fees of $5.30 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2019-02-25
- CONMED CORPORATION legal fees for the quarter ending 2017-12-31 was $500.00K, a 50.00% decline year-over-year.
- CONMED CORPORATION legal fees for the quarter ending 2017-09-30 was $300.00K, a 50.00% decline year-over-year.
- CONMED CORPORATION legal fees for the quarter ending 2017-06-30 was $2.50M, a 78.57% increase year-over-year.
- CONMED CORPORATION legal fees for the quarter ending 2017-03-31 was $2.00M.
- CONMED CORPORATION legal fees for fiscal 2017 was $5.30M, a 39.47% increase from fiscal 2016.
- CONMED CORPORATION legal fees for fiscal 2016 was $3.80M.
- CONMED CORPORATION legal fees for fiscal 2014 was $3.37M, a 5.24% increase from fiscal 2013.
- CONMED CORPORATION legal fees for fiscal 2013 was $3.21M, a 106.17% increase from fiscal 2012.
| Period end | Legal Fees 3 month | Legal Fees 3 month as first filed | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $800.00K derived: sum of 2 quarters · filed 2019-02-25 | $3.30M derived: sum of 3 quarters · filed 2019-02-25 | $5.30M 10-K · filed 2019-02-25 | |
| 2017-09-30 | $300.00K 10-Q · filed 2018-11-02 | $2.80M derived: sum of 2 quarters · filed 2018-11-02 | $4.80M 10-Q · filed 2018-11-02 | $5.80M derived: sum of 4 quarters · filed 2018-11-02 | |
| 2017-06-30 | $2.50M 10-Q · filed 2018-08-02 | $4.50M 10-Q · filed 2018-08-02 | $5.50M derived: sum of 3 quarters · filed 2018-08-02 | $6.10M derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | $2.00M 10-Q · filed 2018-04-26 | $3.00M derived: sum of 2 quarters · filed 2018-04-26 | $3.60M derived: sum of 3 quarters · filed 2018-04-26 | $5.00M derived: sum of 4 quarters · filed 2018-04-26 | |
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.60M derived: sum of 2 quarters · filed 2018-02-26 | $3.00M derived: sum of 3 quarters · filed 2018-02-26 | $3.80M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $600.00K 10-Q · filed 2017-11-02 | $2.00M derived: sum of 2 quarters · filed 2017-11-02 | $2.80M 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $1.40M 10-Q · filed 2017-07-27 | $2.20M 10-Q · filed 2017-07-27 | |||
| 2014-12-31 | $100.00K 10-K · filed 2015-02-23 | $139.00K derived: sum of 2 quarters · filed 2015-02-23 | $1.54M derived: sum of 3 quarters · filed 2015-02-23 | $3.37M 10-K · filed 2015-02-23 | |
| 2014-09-30 | $39.00K 10-Q · filed 2014-10-24 | $1.44M derived: sum of 2 quarters · filed 2015-02-23 | $3.23M 10-Q · filed 2014-10-24 | $4.27M derived: sum of 4 quarters · filed 2015-02-23 | |
| 2014-06-30 | $1.40M 10-K · filed 2015-02-23 | $1.41M 10-Q · filed 2014-07-25 | $3.30M 10-Q · filed 2014-07-25 | $4.24M derived: sum of 3 quarters · filed 2015-02-23 | $5.71M derived: sum of 4 quarters · filed 2015-02-23 |
| 2014-03-31 | $1.83M derived: 10-K 12 month − 3 quarters · filed 2015-02-23 | $2.83M derived: sum of 2 quarters · filed 2015-02-23 | $4.31M derived: sum of 3 quarters · filed 2015-02-23 | $4.84M derived: sum of 4 quarters · filed 2015-02-23 | |
| 2013-12-31 | $1.00M 10-K · filed 2014-02-24 | $2.48M derived: sum of 2 quarters · filed 2014-10-24 | $3.00M derived: sum of 3 quarters · filed 2014-10-24 | $3.21M 10-K · filed 2014-02-24 | |
| 2013-09-30 | $1.48M 10-Q · filed 2014-10-24 | $2.00M derived: sum of 2 quarters · filed 2014-10-24 | $2.21M 10-Q · filed 2014-10-24 | $2.20M derived: sum of 4 quarters · filed 2015-02-23 | |
| 2013-06-30 | $527.00K 10-Q · filed 2014-07-25 | $736.00K 10-Q · filed 2014-07-25 | $727.00K derived: sum of 3 quarters · filed 2015-02-23 | $727.00K derived: sum of 4 quarters · filed 2015-02-23 | |
| 2013-03-31 | $200.00K 10-K · filed 2014-02-24 | $209.00K 10-Q · filed 2013-04-29 | $200.00K derived: sum of 2 quarters · filed 2015-02-23 | $200.00K derived: sum of 3 quarters · filed 2015-02-23 | $700.00K derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $0.00 derived: sum of 2 quarters · filed 2015-02-23 | $500.00K derived: sum of 3 quarters · filed 2015-02-23 | $1.55M 10-K · filed 2015-02-23 | |
| 2012-09-30 | $0.00 10-Q · filed 2013-10-28 | $500.00K derived: sum of 2 quarters · filed 2014-02-24 | $1.55M 10-Q · filed 2013-10-28 | $1.50M derived: sum of 4 quarters · filed 2014-02-24 | |
| 2012-06-30 | $500.00K 10-K · filed 2014-02-24 | $544.00K 10-Q · filed 2012-07-30 | $1.55M 10-Q · filed 2013-07-29 | $1.50M derived: sum of 3 quarters · filed 2014-02-24 | $1.50M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $1.00M 10-K · filed 2014-02-24 | $1.01M 10-Q · filed 2012-05-01 | $1.00M derived: sum of 2 quarters · filed 2014-02-24 | $1.00M derived: sum of 3 quarters · filed 2014-02-24 | $1.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $0.00 derived: sum of 2 quarters · filed 2014-02-24 | $0.00 derived: sum of 3 quarters · filed 2014-02-24 | $0.00 10-K · filed 2014-02-24 | |
| 2011-09-30 | $0.00 10-Q · filed 2012-10-29 | $0.00 derived: sum of 2 quarters · filed 2012-10-29 | $0.00 10-Q · filed 2012-10-29 | ||
| 2011-06-30 | $0.00 10-Q · filed 2012-07-30 | $0.00 10-Q · filed 2012-07-30 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-01 | ||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |